Next Article in Journal
Lactate as a Signaling Molecule That Regulates Exercise-Induced Adaptations
Previous Article in Journal
How Glutamate Is Managed by the Blood–Brain Barrier
Article Menu

Export Article

Open AccessArticle
Biology 2016, 5(4), 39; doi:10.3390/biology5040039

Development of a qPCR Method to Measure Mitochondrial and Genomic DNA Damage with Application to Chemotherapy-Induced DNA Damage and Cryopreserved Cells

1
Biomedical Research Unit, School of Science, University of Waikato Private Bag 3105, Hamilton 3240, New Zealand
2
Department of Oncology, Regional Cancer Centre, Waikato Hospital, Hamilton West 3204, New Zealand
*
Author to whom correspondence should be addressed.
Received: 5 July 2016 / Accepted: 27 September 2016 / Published: 8 October 2016
View Full-Text   |   Download PDF [2368 KB, uploaded 11 October 2016]   |  

Abstract

DNA damage quantitation assays such as the comet assay have focused on the measurement of total nuclear damage per cell. The adoption of PCR-based techniques to quantify DNA damage has enabled sequence- and organelle-specific assessment of DNA lesions. Here we report on an adaptation of a qPCR technique to assess DNA damage in nuclear and mitochondrial targets relative to control. Novel aspects of this assay include application of the assay to the Rotor-Gene platform with optimized DNA polymerase/fluorophore/primer set combination in a touchdown PCR protocol. Assay validation was performed using ultraviolet C radiation in A549 and THP1 cancer cell lines. A comparison was made to the comet assay applied to peripheral blood mononuclear cells, and an estimation of the effects of cryopreservation on ultraviolet C-induced DNA damage was carried out. Finally, dose responses for DNA damage were measured in peripheral blood mononuclear cells following exposure to the cytotoxic agents bleomycin and cisplatin. We show reproducible experimental outputs across the tested conditions and concordance with published findings with respect to mitochondrial and nuclear genotoxic susceptibilities. The application of this DNA damage assay to a wide range of clinical and laboratory-derived samples is both feasible and resource-efficient. View Full-Text
Keywords: LORD-Q; qPCR; comet assay; DNA damage; PBMC; THP1; A549; bleomycin; cisplatin LORD-Q; qPCR; comet assay; DNA damage; PBMC; THP1; A549; bleomycin; cisplatin
Figures

Figure 1a

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Evans, S.O.; Jameson, M.B.; Cursons, R.T.M.; Peters, L.M.; Bird, S.; Jacobson, G.M. Development of a qPCR Method to Measure Mitochondrial and Genomic DNA Damage with Application to Chemotherapy-Induced DNA Damage and Cryopreserved Cells. Biology 2016, 5, 39.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Biology EISSN 2079-7737 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top